4:05 PM ET
8-K
Other 8-K Filing
Maze Therapeutics Other 8-K Filing
Maze Therapeutics entered into an exchange agreement with Frazier Life Sciences to exchange 2,776,007 shares of common stock for pre-funded warrants to purchase an equivalent number of shares. The transaction was conducted under Section 3(a)(9) of the Securities Act, which allows for the exchange of one class of securities for another with no new cash raised.
- Counterparty
- Frazier Life Sciences Public Fund, L.P.